| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | MAGELLAN HEALTH INC COM NEW | 1,450,700 | 101,651,000 | 0.85% | ||
| 102 | PFIZER INC | 3,053,000 | 102,367,000 | 0.86% | ||
| 103 | ALLERGAN PLC | 104,200 | 108,960,000 | 0.91% | ||
| 104 | PUMA BIOTECHNOLOGY | 940,800 | 109,838,000 | 0.92% | ||
| 105 | EXPRESS SCRIPTS HLDG CO | 1,342,000 | 119,357,000 | 1.00% | ||
| 106 | Receptos Inc | 628,100 | 119,370,000 | 1.00% | ||
| 107 | WRIGHT MEDICAL GROUP N.V. | 4,805,000 | 120,077,000 | 1.00% | ||
| 108 | TESARO INCORPORATED | 2,071,480 | 121,782,000 | 1.02% | ||
| 109 | AGILENT TECHNOLOGIES INC | 3,668,000 | 141,511,000 | 1.18% | ||
| 110 | INTUITIVE SURGICAL INC | 301,300 | 145,980,000 | 1.22% | ||
| 111 | IRONWOOD PHARMACEUTICALS INC | 12,402,500 | 149,574,000 | 1.25% | ||
| 112 | BLUEBIRD BIO INC COM | 958,300 | 161,349,000 | 1.35% | ||
| 113 | MEDIVATION INC | 1,413,400 | 161,410,000 | 1.35% | ||
| 114 | MCKESSON CORP | 718,000 | 161,414,000 | 1.35% | ||
| 115 | THERMO FISHER SCIENTIFIC INC | 1,402,000 | 181,924,000 | 1.52% | ||
| 116 | COOPER COS INC | 1,301,400 | 231,610,000 | 1.94% | ||
| 117 | REGENERON PHARMACEUTICALS | 461,800 | 235,578,000 | 1.97% | ||
| 118 | HEALTH NET INC | 3,702,200 | 237,385,000 | 1.98% | ||
| 119 | INCYTE CORP | 2,314,500 | 241,194,000 | 2.02% | ||
| 120 | NEUROCRINE BIOSCIE COM USD0.001 | 5,094,500 | 243,313,000 | 2.03% | ||
| 121 | RELYPSA INC | 7,400,000 | 244,866,000 | 2.05% | ||
| 122 | MOLINA HEALTHCARE INC | 3,487,900 | 245,199,000 | 2.05% | ||
| 123 | ILLUMINA INC | 1,151,000 | 251,332,000 | 2.10% | ||
| 124 | INTERCEPT PHARMACEUTICALS INCORPORATED | 1,120,000 | 270,346,000 | 2.26% | ||
| 125 | IMPAX LABORATORIES INC | 6,739,200 | 309,464,000 | 2.59% | ||
| 126 | SHIRE PLC | 1,306,000 | 315,386,000 | 2.64% | ||
| 127 | GILEAD SCIENCES INC | 2,895,400 | 338,993,000 | 2.83% | ||
| 128 | ALEXION PHARMACEUTIC | 2,044,400 | 369,566,000 | 3.09% | ||
| 129 | BOSTON SCIENTIFIC CORP | 21,680,000 | 383,736,000 | 3.21% | ||
| 130 | AMGEN INC | 2,881,000 | 442,291,000 | 3.70% | ||
| 131 | CELGENE CORP | 3,826,000 | 442,802,000 | 3.70% | ||
| 132 | ABBVIE INC | 6,665,000 | 447,821,000 | 3.74% | ||
| 133 | HCA HOLDINGS INC | 5,017,400 | 455,179,000 | 3.80% | ||
| 134 | ALLERGAN PLC | 1,511,315 | 458,624,000 | 3.83% | ||
| 135 | BRISTOL MYERS SQUIBB CO | 7,751,100 | 515,758,000 | 4.31% | ||
| 136 | BIOGEN INC | 1,278,900 | 516,599,000 | 4.32% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001654, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
